Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 23, 1998

View Archived Issues

Oxford BioMedica, RPR In £11 million Deal

Mologen, Virbac Enter Agreement For Vaccines

Australian Food Industry Assails Labeling Decision

British Biotech Drops One Marimastat Study

Early Progen Study Finds Enzyme Blocker Effective

Antisoma Raises £10M, Achieves Market Listing

Australia's Biotech Market Lacks Depth, Analysts Say

Xenova Plans Phase II Study Of Cancer Drug

Chiroscience Mulls Strategy For Anesthetic's Marketing

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...